Literature DB >> 21325063

MicroRNA expression signature in atrial fibrillation with mitral stenosis.

Junjie Xiao1, Dandan Liang, Yangyang Zhang, Yi Liu, Hong Zhang, Ying Liu, Li Li, Xingqun Liang, Yunfu Sun, Yi-Han Chen.   

Abstract

The aim of this study was to investigate the microRNA (miRNA) signature in atrial fibrillation (AF) with mitral stenosis (MS). miRNA arrays were used to evaluate the expression signature of the right atrial appendages of healthy individuals (n=9), patients with MS and AF (n=9) and patients with MS without AF (n=4). The results were validated with qRT-PCR analysis. GOmir was used to predict the potential miRNA targets and to analyze their functions. DIANA-mirPath was used to incorporate the miRNAs into pathways. miRNA arrays revealed that 136 and 96 miRNAs were expressed at different levels in MS patients with AF and in MS patients without AF, respectively, compared with healthy controls. More importantly, 28 miRNAs were expressed differently in the MS patients with AF compared with the MS patients without AF; of these miRNAs, miR-1202 was the most dysregulated. The unsupervised hierarchical clustering analysis based on the 28 differently expressed miRNAs showed that the heat map of miRNA expression categorized two well-defined clusters that corresponded to MS with AF and MS without AF. The qRT-PCR results correlated well with the microarray data. Bioinformatic analysis indicated the potential miRNA targets and molecular pathways. This study shows that there is a distinct miRNA expression signature in AF with MS. The findings may be useful for the development of therapeutic interventions that are based on rational target selection in these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325063     DOI: 10.1152/physiolgenomics.00139.2010

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  42 in total

Review 1.  Advances in exploring the role of microRNAs in the pathogenesis, diagnosis and therapy of cardiac diseases in China.

Authors:  Z W Pan; Y J Lu; B F Yang
Journal:  Br J Pharmacol       Date:  2015-01-20       Impact factor: 8.739

Review 2.  Common variants for atrial fibrillation: results from genome-wide association studies.

Authors:  Xinyuan Liu; Fei Wang; Ashley C Knight; Jiangmin Zhao; Junjie Xiao
Journal:  Hum Genet       Date:  2011-07-07       Impact factor: 4.132

3.  Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure.

Authors:  Junjie Xiao; Rongrong Gao; Yihua Bei; Qiulian Zhou; Yanli Zhou; Haifeng Zhang; Mengchao Jin; Siqi Wei; Kai Wang; Xuejuan Xu; Wenming Yao; Dongjie Xu; Fang Zhou; Jingfa Jiang; Xinli Li; Saumya Das
Journal:  Cell Physiol Biochem       Date:  2017-02-16

4.  MicroRNA expression signatures of atrial fibrillation: The critical systematic review and bioinformatics analysis.

Authors:  Nan-Nan Shen; Chi Zhang; Zheng Li; Ling-Cong Kong; Xin-Hua Wang; Zhi-Chun Gu; Jia-Liang Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-25

Review 5.  MicroRNA regulation of cardiac conduction and arrhythmias.

Authors:  Gene H Kim
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

6.  Pitx2-microRNA pathway that delimits sinoatrial node development and inhibits predisposition to atrial fibrillation.

Authors:  Jun Wang; Yan Bai; Na Li; Wenduo Ye; Min Zhang; Stephanie B Greene; Ye Tao; Yiping Chen; Xander H T Wehrens; James F Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-10       Impact factor: 11.205

7.  Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release.

Authors:  David Y Chiang; Natee Kongchan; David L Beavers; Katherina M Alsina; Niels Voigt; Joel R Neilson; Heinz Jakob; James F Martin; Dobromir Dobrev; Xander H T Wehrens; Na Li
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-11-11

8.  Microarray analysis reveals altered circulating microRNA expression in mice infected with Coxsackievirus B3.

Authors:  Chaoyu Sun; Lei Tong; Wenran Zhao; Yan Wang; Yuan Meng; Lexun Lin; Bingchen Liu; Yujia Zhai; Zhaohua Zhong; Xueqi Li
Journal:  Exp Ther Med       Date:  2016-08-22       Impact factor: 2.447

Review 9.  MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle.

Authors:  Ahmed Omran; Dalia Elimam; Keith A Webster; Lina A Shehadeh; Fei Yin
Journal:  Cardiol Young       Date:  2013-02-26       Impact factor: 1.093

10.  MicroRNA-221 is required for proliferation of mouse embryonic stem cells via P57 targeting.

Authors:  Jin Li; Yihua Bei; Qi Liu; Dongchao Lv; Tianzhao Xu; Yanyun He; Ping Chen; Junjie Xiao
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.